Cabaletta Bio, Inc. (CABA)

Cabaletta Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	193.24	81.61	122.22	101.43	136.2
Short-Term Investments	48.01	24.94	0	7.23	0
Cash & Cash Equivalents	241.25	106.55	122.22	108.66	136.2
Cash Growth	126.42%	-12.83%	12.48%	-20.22%	312.53%
Other Current Assets	3.24	2.29	2.32	4.87	4.35
Total Current Assets	244.49	108.83	124.54	113.54	140.55
Property, Plant & Equipment	7.45	7.57	1.44	0.89	0.82
Other Long-Term Assets	1.71	0.57	0.36	0.3	0.1
Total Long-Term Assets	9.16	8.13	1.8	1.19	0.92
Total Assets	253.65	116.97	126.34	114.72	141.47
Accounts Payable	4.55	2.46	2.33	1.24	0.92
Current Debt	3.56	2.18	0	0	0
Other Current Liabilities	7.89	4.85	6.05	3.94	2.23
Total Current Liabilities	15.99	9.49	8.38	5.18	3.15
Long-Term Debt	1.46	2.96	0	0	0
Total Long-Term Liabilities	1.46	2.96	0	0	0
Total Liabilities	17.45	12.45	8.38	5.18	3.15
Total Debt	5.02	5.14	0	0	0
Debt Growth	-2.34%	-	-	-	-
Retained Earnings	-233.24	-165.56	-112.59	-66.3	-32.96
Comprehensive Income	0.04	-0.05	0	0.01	0
Shareholders' Equity	236.2	104.52	117.96	109.54	138.32
Net Cash / Debt	236.23	101.41	122.22	108.66	136.2
Net Cash / Debt Growth	132.95%	-17.03%	12.48%	-20.22%	312.53%
Working Capital	228.5	99.35	116.16	108.36	137.41
Book Value Per Share	5.51	3.60	4.16	4.55	5.75

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).